- Review
Auxotrophic Mycobacterium bovis BCG: Updates and Perspectives
- Odir Antônio Dellagostin,
- Sibele Borsuk,
- Thaís Larré Oliveira and
- Fabiana Kömmling Seixas
Mycobacterium bovis BCG has been used for a century as the only licensed vaccine against tuberculosis. Owing to its strong adjuvant properties, BCG has also been employed as an oncological immunotherapeutic as well as a live vaccine vector against ot...